Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,010.31
-4.18 (-0.41%)
At close: Dec 5, 2025, 4:00 PM EST
1,014.40
+4.09 (0.40%)
After-hours: Dec 5, 2025, 7:59 PM EST
Eli Lilly and Company (LLY) Revenue by Segment
History
| Date | Diabetes | Oncology | Immunology | Animal Health | Cardiovascular | Other | Neuroscience |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 42.84B | 9.32B | 5.00B | 3.14B | 2.25B | 942.20M | 1.32B |
| Jun 30, 2025 | 37.06B | 9.14B | 4.82B | 3.12B | 2.54B | 867.80M | 1.36B |
| Mar 31, 2025 | 33.24B | 8.89B | 4.65B | 3.08B | 2.62B | 873.90M | 1.36B |
| Dec 31, 2024 | 29.52B | 8.75B | 4.39B | 3.08B | 2.74B | 902.90M | 1.47B |
| Sep 30, 2024 | 26.16B | 8.08B | 4.21B | 3.09B | 2.87B | 968.50M | 1.44B |
| Jun 30, 2024 | 23.47B | 7.60B | 4.01B | 3.13B | 3.04B | 981.80M | 2.86B |
| Mar 31, 2024 | 20.97B | 7.11B | 3.85B | 3.10B | 3.15B | 1.09B | 2.91B |
| Dec 31, 2023 | 19.67B | 6.66B | 3.80B | 3.17B | 3.17B | 1.12B | 2.88B |
| Sep 30, 2023 | 17.90B | 6.43B | 3.63B | 3.16B | 3.23B | 1.22B | 2.90B |
| Jun 30, 2023 | 16.84B | 5.97B | 3.51B | - | - | 1.69B | 1.51B |
| Mar 31, 2023 | 15.27B | 5.67B | 3.37B | - | - | 1.87B | 1.51B |
| Dec 31, 2022 | 14.46B | 5.67B | 3.34B | - | - | 3.52B | 1.55B |
| Sep 30, 2022 | 14.12B | 5.42B | 3.37B | - | - | 4.70B | 1.63B |
| Jun 30, 2022 | 13.73B | 5.54B | 3.51B | - | - | 4.59B | 1.71B |
| Mar 31, 2022 | 13.47B | 5.72B | 3.49B | - | - | 4.81B | 1.83B |
| Dec 31, 2021 | 13.19B | 5.74B | 3.36B | - | - | 4.13B | 1.90B |
| Sep 30, 2021 | 12.86B | 5.85B | 3.10B | - | - | 4.04B | 1.90B |
| Jun 30, 2021 | 12.37B | 5.78B | 2.73B | - | - | 3.93B | 1.92B |
| Mar 31, 2021 | 11.98B | 5.49B | 2.49B | - | - | 3.70B | 1.83B |
| Dec 31, 2020 | 11.83B | 5.32B | 2.46B | - | - | 3.09B | 1.83B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.